O'Shaughnessy Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,582	Closed	-$53K	–	2938
2021 Q2	$53K	Buy	+1,582	New	+$40.3K	﹤0.01%	1567

O'Shaughnessy Asset Management's CNST Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,582 shares — an estimated $53K sold.

O'Shaughnessy Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $53K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

O'Shaughnessy Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 1,582 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $53K.
O'Shaughnessy Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
O'Shaughnessy Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $53K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.